We are participants and witnesses to history. The community of scientists, scholars, activists, entrepreneurs, journalists, and investors that make up the CBDCON community will look back on the week that the Fortune 500 Constellation Brands (Corona among others) invested in Canopy as a monumental invent for CBD.



Constellation wants to get a head start in marketing cannabis-infused beverages in the United States and the fastest path to that option is to use CBD. While the federal government sorts out its views on legal cannabis nationwide, CBD presents a wedge to get into mainstream America. Companies like Sonoma-based Care by Design have already developed methods to remove nearly all of the THC from their CBD products. CBD will have its moment in 2018 because so many established companies (WalMart/Target) want in on the Cannabis market and CBD is the safe way for them to play.



CBDCON will coalesce our community and advance our agenda. Stick with us to follow all the CBD news worldwide and expect us to start doing more original journalism in the weeks to come.



In the meantime, if there’s a story, company, brand, project that you think CBDCON needs to know about don’t hesitate to contact us. You can email directly to our Managing Editor Mostafa El Manzalawy.



It’s time to organize and advance our cause and we look forward to catalyzing change.



Faithfully,



Aaron Cohen

Founder, Editor CBDCON



P.S. Spread the word to your friends/colleagues/family/loved ones/enemies/former significant others/burning man camp/teammates/therapists/life coach/personal trainer/neighbor who you think works in pharma but you’re not totally sure. Have them subscribe.